Key Moments
#68–Marty Makary, MD: US healthcare system—why it’s broken, how to fix it, & how to protect yourself
Peter Attia MDKey Moments
US healthcare is broken by price gouging and administrative waste, but transparency and new models offer hope.
Key Insights
The US healthcare system is characterized by exorbitant, non-transparent pricing and significant administrative waste, making it the highest-cost system globally.
A major driver of inflated costs is a complex web of intermediaries, including Pharmacy Benefit Managers (PBMs) and brokers, who often operate with hidden fees and kickbacks.
The system's structure lacks long-term financial incentives for health insurers and providers to focus on preventive care, as patients frequently switch plans/providers.
Despite being well-intentioned, medical professionals contribute to waste through fear of malpractice, leading to excessive diagnostic testing and over-treatment.
Patients are often victimized by "surprise bills" and predatory collection practices, leading to medical debt and financial ruin for many.
Solutions involve radical price transparency, direct employer-to-provider contracts, globally capitated primary care models, legislative action against kickbacks, and active patient advocacy.
The inherent culture of medicine (e.g., medical education, lack of emotional support for providers) also plays a role in system dysfunction and physician burnout.
A BROKEN SYSTEM: THE HIGH COST OF HEALTHCARE
The US healthcare system is profoundly broken, marked by astonishingly high costs and a pervasive lack of transparency. It has become the nation's number one industry, absorbing a significant portion of GDP and state budgets (e.g., 43% in Massachusetts). This financial burden often translates into overwhelming medical bills for everyday Americans, regardless of insurance status. Many find themselves subjected to predatory pricing, leading to medical debt, ruined credit scores, and even personal bankruptcy—a reality for one in five Americans. The frustration stems from an inability to understand the true cost of care, with bills often being arbitrary and disconnected from actual value, a dynamic Dr. Makary likens to the confusing 'Big Short' of the financial crisis.
THE ROLE OF MIDDLEMEN AND HIDDEN FEES
A core issue lies with intermediaries like Pharmacy Benefit Managers (PBMs) and insurance brokers who inflate costs through opaque practices. PBMs, acting on behalf of employers, negotiate drug prices but often prioritize rebates (kickbacks) from pharmaceutical companies over the lowest possible cost for the consumer or employer. These rebates are built into drug prices, obscuring the true market value. Similarly, many healthcare brokers receive undisclosed commissions from insurance companies, disincentivizing them from finding the best deals for their clients. This complex web of hidden financial incentives and kickbacks makes genuine price comparison and negotiation virtually impossible for businesses and individuals alike, driving up premiums and out-of-pocket expenses.
INSURANCE COMPANIES AND MISALIGNED INCENTIVES
Insurance companies, while seemingly negotiating rates, sometimes lack the true fiduciary incentive to secure the lowest prices. Regulations like the Medical Loss Ratio (MLR), which mandates insurers spend 80% of premiums on claims, can inadvertently encourage higher payouts to justify higher premiums and thus higher profits (20% of a larger pie). Furthermore, the frequent switching of insurance plans by individuals (average tenure often less than four years) disincentivizes long-term investment in preventive care. An insurer has little financial motivation to prevent a chronic disease that might cost heavily in 20 years if that patient will likely be with a competitor by then, leading to short-sighted care decisions.
OVER-TREATMENT AND MALPRACTICE FEARS
Medical professionals, despite their dedication, contribute to system waste. Surveys indicate that a significant portion (around 21%) of medical services are deemed unnecessary by practitioners themselves. This often stems from a 'cover-your-ass' culture driven by an overly litigious environment. Physicians may order excessive diagnostic tests, such as head CTs for minor headaches, not because they are medically essential, but to mitigate the perceived risk of a potential malpractice lawsuit if a rare condition were missed. While the direct costs of malpractice insurance are a small fraction of overall healthcare spending, the indirect costs from defensive medicine are substantial, creating a cycle of fear-driven, inappropriate care.
PREDATORY BILLING AND PATIENT VULNERABILITY
Patients are frequently subjected to "surprise bills" and aggressive collection tactics, even for services within their insurance network if an ancillary provider (e.g., an anesthesiologist) is out-of-network. Hospitals, often non-profits, have been found to sue low-income patients, garnish wages, and even drain bank accounts for unpaid medical debts. These egregious bills often lack a clear legal contract, as patients are asked to sign complex forms under duress in urgent situations, yet they are pursued relentlessly by "revenue cycle departments" and collection agencies. Patients often believe these bills are non-negotiable, but they are, and challenging them can often lead to significant reductions.
THE 'DID NOT READ' STRATEGY
To protect themselves from predatory billing, patients are advised to challenge medical bills vigorously. If asked to sign forms during an urgent medical encounter, individuals can write 'did not read' next to their signature, weakening the legal standing of any supposed pricing agreement. It is crucial to demand a copy of the contract or agreement that legally obligates payment, as collection agencies often cannot produce one for arbitrary charges. Furthermore, engaging with state attorneys general, local news (though some may be influenced by hospital advertising), and advocacy groups can expose and challenge unjust billing practices, empowering individuals to fight for fair treatment.
MARKET-DRIVEN SOLUTIONS: TRANSPARENCY AND CAPITATION
While a single-payer system could eliminate many of these money games, Dr. Makary advocates for market-driven solutions that leverage competition and transparency to avoid the historical pitfalls of government-controlled systems (e.g., eventual budget cuts, diluting quality). Models like globally capitated primary care clinics (e.g., ChenMed, Oak Street Health) offer a promising path. In these systems, providers receive a lump sum per patient, aligning incentives for long-term health outcomes rather than fee-for-service. This encourages proactive, preventive care, reduces unnecessary procedures, and cuts costs by assuming downstream financial risk for patient health. Businesses can also seek independent brokers and directly contract with healthcare systems, bypassing opaque intermediaries.
THE CALL FOR PHYSICIAN ADVOCACY AND CULTURAL SHIFT
Physicians, by virtue of their public trust, are urged to actively champion reform. They can challenge the prevailing "deny and defend" mentality propagated by risk managers after medical errors, fostering honest communication with patients. Moreover, medical education needs reform, moving beyond rote memorization to instill empathy, communication skills, and an understanding of the business of medicine. Doctors can advocate for a hospital code of conduct that mandates transparent billing, prohibits suing low-income patients for basic care, and uses Medicare allowable amounts as a benchmark for direct patient bills. This cultural shift, driven by a return to medicine's altruistic heritage, is essential to restore public trust.
GRASSROOTS MOVEMENTS AND COMMUNITY ENGAGEMENT
The energy for reform is building from the grassroots. Organizations like 'Restoring Medicine' are mobilizing students and professionals to advocate for change. Everyday citizens are encouraged to engage with their local hospitals, especially given that many are non-profit community organizations. Key actions include inquiring about the hospital's average markup (how much they charge above Medicare's allowable amount), their policies for uninsured or low-income patients, and checking court records for lawsuits against patients. Appealing to hospital board members, who are often local business leaders, can bring pressure for ethical billing practices and greater transparency, fostering a more patient-centered and financially responsible healthcare environment.
CHALLENGING DRUG PRICING AND ANTI-TRUST EXEMPTIONS
Drug pricing remains a significant issue, with Americans paying far more for medications than other countries. While high development costs are often cited, the problem is exacerbated by bad actors delaying generic competition and the PBM rebate system. PBMs demand large 'access fees' or 'kickbacks' from pharmaceutical companies to include drugs in their formularies, which are then built into the drug's price. This practice is enabled by a 'safe harbor' provision in 1987 legislation, exempting PBMs and Group Purchasing Organizations (GPOs) from certain antitrust laws. Revoking this safe harbor and banning all kickbacks in healthcare is seen as crucial to fostering genuine competition and reducing drug costs.
THE OPTIMISTIC OUTLOOK FOR REFORM
Despite the systemic challenges, there is a strong sense of optimism for the future of healthcare. The increasing public awareness and frustration with inflated medical bills are creating a powerful demand for change. Innovative models, such as Keith Smith's Surgery Center of Oklahoma, offer bundled, transparent pricing, attracting patients from across the globe and demonstrating the viability of competitive, honest healthcare. The willingness of younger generations, physicians, and civic leaders to challenge the status quo and demand accountability suggests a tipping point where market forces, guided by transparency and ethical principles, can drive meaningful and lasting reform, making quality healthcare accessible without financial devastation.
Mentioned in This Episode
●Software & Apps
●Companies
●Organizations
●Books
●People Referenced
Common Questions
Makary witnessed systemic failures in hospitals, such as unaddressed safety hazards and doctors proceeding with invasive procedures against patients' wishes. These experiences highlighted a disconnect between medical intentions and actual patient care, inspiring him to write 'Unaccountable' to educate the public on patient safety and the importance of questioning care.
Topics
Mentioned in this video
The author of a book Peter Pronovost recommended to Peter Attia when he was contemplating leaving medicine, suggesting its philosophical nature might offer guidance.
A medical professional in Oklahoma City who offers transparent, bundled pricing for all services at his medical center, disrupting traditional healthcare billing and earning the disdain of insurance companies while attracting patients globally.
An ICU doctor and Marty Makary's official mentor at Johns Hopkins, known for developing the ICU checklist which inspired the surgical checklist. He was also supportive of Peter Attia's decision to leave medicine.
Head of Neurology at Northwestern and a former colleague of Peter Attia and Marty Makary from their training days.
Inventor of the polio vaccine, noted for his altruism in refusing to patent it, believing it to be the 'property of humanity,' thus ensuring its widespread dissemination.
Former US President, who recognized Benjamin Rush's contributions to mankind as greater than Benjamin Franklin's, highlighting Rush's impact on society.
Host of The Drive podcast, discussing his professional background and commitment to listener-supported content, and sharing personal experiences from his time as a surgical resident at Johns Hopkins.
A leader in the field of patient safety at Harvard, whom Marty Makary worked with as a medical student. He championed the study of medical mistakes and their impact on patients.
Former head of the FDA, who advocated for pharmaceutical companies to more quickly release manufacturing information for generic drugs once patents expire, to prevent continuous gouging.
Another impressive individual in the Trump administration who supported price transparency initiatives in healthcare.
A highly esteemed and famous surgeon at Johns Hopkins, known for his expertise in pancreatic surgery and his role in medical education, including 'Sunday School' for interns.
Pioneering surgeon who created the surgical residency program at Johns Hopkins in the late 1800s, establishing a significant lineage in surgical training.
A Founding Father of the United States, whose contributions were compared to Benjamin Rush's by President John Adams, with Rush's being considered greater in the context of patient advocacy.
One of the founding physicians of Johns Hopkins Hospital, a key figure in modern medicine often referenced for his contributions to medical education and clinical practice.
An impressive individual in the Trump administration who supported price transparency in healthcare.
A professor of surgical oncology and chief of the islet transplant center at Johns Hopkins. A pioneering surgeon in minimally invasive pancreatic surgery and co-creator of the surgical checklist. Author of 'Unaccountable' and 'The Price We Pay', focusing on medical errors and the broken healthcare system.
A former pediatric neurosurgeon at Johns Hopkins who, in a humorous anecdote, was mistakenly identified by a medical student as the inventor of the Bovie.
Another leader in patient safety at Harvard, who, along with Lucian Leape, were considered radicals for promoting the study of medical errors.
The actual first neurosurgeon who trained under William Stewart Halsted at Johns Hopkins and later moved to Boston, creating the field of modern neurosurgery and inventing the Bovie.
The founder of Health Rosetta, an organization dedicated to promoting transparency and fair practices among healthcare brokers.
The entrepreneur and business magnate, whose disruptive success is compared to Keith Smith's innovation in healthcare despite opposition from established players.
One of the five physician signers of the Declaration of Independence, remembered for his humanitarian work in destigmatizing mental illness and being a role model for patient advocacy.
An impressive individual in the Trump administration who supported price transparency, pushing for hospitals to submit their prices.
Legislation that included the Medical Loss Ratio (MLR), requiring insurance companies to spend 80% of premiums on claims payouts, unintentionally incentivizing higher overall payouts to maximize profit.
A government health insurance program that is used as a benchmark for allowable amounts for medical services. Discussed in the context of potential cost savings with a Medicare for All system.
A United States law that requires hospitals to provide care to any urgent or emergent patient, regardless of their ability to pay or provide insurance information, making signing forms under duress potentially null and void for financial obligations.
A US law that promotes fair competition. PBMs and GPOs have benefited from a 1987 'safe harbor' law that grants them exclusivity, effectively exempting them from aspects of this act in the healthcare supply chain.
A personal genomics and biotechnology company mentioned as a benchmark for the low cost of extensive genetic testing, contrasted with the thousands of dollars charged for single gene allele tests in traditional healthcare.
Another example of a globally capitated primary care clinic, similar to ChenMed, offering long-term care by assuming financial risk.
A recommended app that helps consumers find the cash price of prescription drugs, often revealing prices lower than insurance co-pays and employer charges.
Mentioned as an example of a large company with giant cash reserves that could potentially self-fund its employees' healthcare, managing the risk internally rather than relying on traditional insurance.
A globally capitated primary care clinic in Florida, founded by the Chen family, known for its innovative approach to healthcare by assuming the long-term financial risk for patients, leading to better patient outcomes and lower costs.
An insurance company example used in the context of Apple paying for administrative management of healthcare plans while holding the risk internally. Also Peter Attia's current insurance provider.
A global initiative that adopted the surgical checklist co-created by Marty Makary, aimed at improving patient safety and preventing medical errors during surgical procedures.
A renowned medical institution where Peter Attia and Marty Makary completed their residencies and currently work. Described as a special place with exceptional individuals and a strong historical lineage in medicine.
A middleman entity in the drug supply chain that negotiates drug prices between pharmaceutical companies and insurers/employers. Described as engaging in 'shell games' and 'kickbacks' through rebates, leading to inflated drug costs.
The U.S. Food and Drug Administration, whose former head, Scott Gottlieb, addressed the issue of pharmaceutical companies delaying generic drug information after patents expire.
A grassroots movement started by medical students at Johns Hopkins and across the country to fight predatory billing practices and advocate for transparent, fair pricing in healthcare. It also hosts resources and a code of conduct for medical centers.
A large capitated healthcare system on the West Coast, cited as the traditional example of capitation in modern healthcare.
A hospital in Washington D.C. where Marty Makary witnessed a tragic incident involving a preventable elevator shaft fall, highlighting systemic failures in learning from mistakes.
A hospital in Annapolis, Maryland, where Marty Makary serves on the board. He uses it as an example of a good community organization to engage for healthcare reform.
A movie mentioned alongside 'Hurt Locker' to further illustrate the psychological impact of highly stressful professions, leading to emotional detachment.
A popular television show based on Marty Makary's book 'Unaccountable', which dramatizes the business of medicine and medical errors. It provided a powerful depiction of a patient's wish to refuse treatment.
A movie mentioned by Marty Makary to illustrate how traumatic experiences can lead individuals to become emotionally detached or 'robots,' drawing parallels to doctors' internalization of difficult cases.
A movie that eloquently described complex financial tools leading to the mortgage meltdown. Marty Makary aims for his book 'The Price We Pay' to serve a similar explanatory role for healthcare.
Marty Makary's first New York Times bestselling book, which became the basis for 'The Resident' TV show. It discusses medical errors, patient safety, and the importance of second opinions.
Marty Makary's upcoming book that addresses the broken US healthcare system, focusing on predatory pricing, administrative waste, and over-treatment.
More from Peter Attia MD
View all 322 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free